BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 30457328)

  • 1. New Variations on the Theme of Gold(III) C
    Carboni S; Zucca A; Stoccoro S; Maiore L; Arca M; Ortu F; Artner C; Keppler BK; Meier-Menches SM; Casini A; Cinellu MA
    Inorg Chem; 2018 Dec; 57(23):14852-14865. PubMed ID: 30457328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
    Li CK; Sun RW; Kui SC; Zhu N; Che CM
    Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
    Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
    Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (C^N
    Williams M; Green AI; Fernandez-Cestau J; Hughes DL; O'Connell MA; Searcey M; Bertrand B; Bochmann M
    Dalton Trans; 2017 Oct; 46(39):13397-13408. PubMed ID: 28945262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles.
    Massai L; Cirri D; Michelucci E; Bartoli G; Guerri A; Cinellu MA; Cocco F; Gabbiani C; Messori L
    Biometals; 2016 Oct; 29(5):863-72. PubMed ID: 27476157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkyl chain-modified cyclometalated iridium complexes as tunable anticancer and imaging agents.
    Laha P; De U; Chandra F; Dehury N; Khullar S; Kim HS; Patra S
    Dalton Trans; 2018 Nov; 47(44):15873-15881. PubMed ID: 30358775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships in cytotoxic Au(I)/Au(III) complexes derived from 2-(2'-pyridyl)benzimidazole.
    Maiore L; Aragoni MC; Deiana C; Cinellu MA; Isaia F; Lippolis V; Pintus A; Serratrice M; Arca M
    Inorg Chem; 2014 Apr; 53(8):4068-80. PubMed ID: 24679072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclometalated Gold(III) Complexes Bearing DACH Ligands.
    Gukathasan S; Parkin S; Awuah SG
    Inorg Chem; 2019 Jul; 58(14):9326-9340. PubMed ID: 31247820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of Pyrazine-Based Cyclometalated (C^N
    Bertrand B; Fernandez-Cestau J; Angulo J; Cominetti MMD; Waller ZAE; Searcey M; O'Connell MA; Bochmann M
    Inorg Chem; 2017 May; 56(10):5728-5740. PubMed ID: 28441013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
    Sanghvi CD; Olsen PM; Elix C; Peng SB; Wang D; Chen ZG; Shin DM; Hardcastle KI; MacBeth CE; Eichler JF
    J Inorg Biochem; 2013 Nov; 128():68-76. PubMed ID: 23948576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper(II) complexes based on tripodal pyrazolyl amines: Synthesis, structure, magnetic properties and anticancer activity.
    Massoud SS; Louka FR; Ducharme GT; Fischer RC; Mautner FA; Vančo J; Herchel R; Dvořák Z; Trávníček Z
    J Inorg Biochem; 2018 Mar; 180():39-46. PubMed ID: 29232637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed-Ligand Cobalt(III) Complexes of a Naturally Occurring Coumarin and Phenanthroline Bases as Mitochondria-Targeted Dual-Purpose Photochemotherapeutics.
    Sarkar T; Kumar A; Sahoo S; Hussain A
    Inorg Chem; 2021 May; 60(9):6649-6662. PubMed ID: 33855849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties.
    Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR
    Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural characterization, solution studies, and DFT calculations on a series of binuclear gold(III) oxo complexes: relationships to biological properties.
    Gabbiani C; Casini A; Messori L; Guerri A; Cinellu MA; Minghetti G; Corsini M; Rosani C; Zanello P; Arca M
    Inorg Chem; 2008 Apr; 47(7):2368-79. PubMed ID: 18314951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses, Structures, and Antimicrobial Activities of Gold(I)- and Copper(I)- N-Heterocyclic Carbene (NHC) Complexes Derived from Basket-Shaped Dinuclear Ag(I)-NHC Complex.
    Nomiya K; Morozumi S; Yanagawa Y; Hasegawa M; Kurose K; Taguchi K; Sakamoto R; Mihara K; Kasuga NC
    Inorg Chem; 2018 Sep; 57(18):11322-11332. PubMed ID: 30168718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
    Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L
    Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches.
    Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A
    Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
    Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
    J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luminescent Re(I)/Au(I) Species As Selective Anticancer Agents for HeLa Cells.
    Luengo A; Redrado M; Marzo I; Fernández-Moreira V; Gimeno MC
    Inorg Chem; 2020 Jul; 59(13):8960-8970. PubMed ID: 32420746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.